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Quality  of  life;
Ex  post  facto  study
Abstract  Background/Objective:  Depression,  anxiety,  fatigue,  and  sleep  problems  are  typical
conditions  reported  in people  with  multiple  sclerosis  (MS),  often  resulting  in a  reduction  of  their
quality of  life  (QOL)  and  well-being.  Mindfulness  is a  multifaceted  and  complex  construct  that
has been  increasingly  explored  for  its  correlated  to  well-being.  Despite  preliminary  evidence,
longitudinal  data  about  the  impact  of  mindfulness  on  QOL  in MS remain  limited.  In  addition,  Lan-
gerian mindfulness,  one  of  the  prominent  approaches  to  mindfulness,  is yet  unexplored  in  this
field. The  study  aims  to  examine  the  longitudinal  relationships  between  two  forms  of  mindful-
ness (Langerian  and  contemplative)  and QOL,  anxiety,  depression,  fatigue,  and  sleep.  Method:
Within a  larger  randomized  controlled  trial  of  an  online  mindfulness-based  stress  reduction
intervention,  a  cohort  of  156  people  with  MS  was  recruited  and  assessed  for  both  mindfulness
constructs,  QOL,  anxiety,  depression,  fatigue,  and  sleep  problems.  Assessments  were  repeated
after 2 and  after  another  6  months.  Results:  Both  mindfulness  constructs  were  highly  correlated
with all  investigated  outcomes.  Both  Langerian  and  contemplative  mindfulness  predicted  higher
QOL, lower  anxiety,  depression,  fatigue,  and  sleep,  over  time.  Conclusions:  In  both  approaches
dispositional  mindfulness  is a  protective  factor  against  depression,  anxiety,  fatigue,  and  sleep
in people  with  MS.
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calidad  de  vida;
estudio  ex  post  facto
Asociaciones  longitudinales  entre  el  mindfulness  y el  bienestar  en  personas  con
esclerosis  múltiple
Resumen  Antecedentes/Objetivo:  La  depresión,  la  ansiedad,  la  fatiga  y  los  problemas  para
dormir son  condiciones  típicas  en  personas  con  esclerosis  múltiple  (EM),  que  a  menudo  conll-
evan una  reducción  de su calidad  de vida  (CV).  El mindfulness  es una  construcción  compleja
y multifacética  que  ha sido  cada  vez más  explorada  por  su correlación  con  el  bienestar.  Sin
embargo, los  datos longitudinales  sobre  el impacto  del  mindfulness  en  la  calidad  de  vida  en  la
EM siguen  siendo  limitados.  Este estudio  tiene  como  objetivo  examinar  las  relaciones  longitu-
dinales  entre  dos  formas  de  mindfulness  con  la  calidad  de  vida,  la  ansiedad,  la  depresión,  la
fatiga  y  el  sueño.  Método:  Se contó  con  una  muestra  de 156  personas  con  EM  y  se  evaluaron  los
constructos  de  mindfulness,  calidad  de vida,  ansiedad,  depresión,  fatiga  y  problemas  de  sueño.
Las evaluaciones  se  repitieron  después  de  2  y  6 meses.  Resultados:  Ambos  constructos  de  mind-
fulness estuvieron  altamente  correlacionados  con  todos  los  resultados  investigados,  y  ambos
predijeron mayor  CV, menor  ansiedad,  depresión,  fatiga  y  problemas  de sueño  con  el tiempo.
Conclusiones:  El  mindfulness  es  un  factor  de  protección  contra  la  depresión,  la  ansiedad,  la
fatiga  y  el  sueño  en  personas  con  EM.
© 2018  Asociación Española  de Psicoloǵıa  Conductual.  Publicado  por  Elsevier  España,  S.L.U.
Este es  un  art́ıculo  Open  Access  bajo  la  licencia  CC BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
Multiple  sclerosis  (MS)  is  a  chronic  degenerative  disease
of  the  central  nervous  system  that  involves  functionality
of  the  brain  and  spinal cord,  with  physical,  sensory,  cog-
nitive  and  emotional  responses  ranging from  mild  to  severe
(Ontaneda,  Thompson,  Fox,  &  Cohen,  2017).  The  relatively
high  variability  in  symptomatology  is  determined  primarily
by  the  location  of  the  lesions  in  the  brain  and spinal  cord.
Lesions  in the frontal  and parietal  lobes  may  result  in cogni-
tive  and  emotional  problems;  plaques  in the  cerebrum,  brain
stem  and  spinal  cord  may  determine  functional  limitations  of
extremities  (Rumrill,  2009). Although  illness-related  factors
(such  as neurological  deterioration  and functional  disabil-
ity)  can  contribute  to  how  well  the person  with  MS adjusts,
the  psychological  response  to  the highly  stressful  nature  of
this  disease  is very  important  for the person’s  quality  of
life  (QOL).  In particular,  the individual’s  beliefs regarding
the  uncertainty  of  the  disease  and  the perceived  intrusive-
ness  on daily  activities  are  important  factors  in depression,
anxiety,  and adjustment  to  the illness  (Mullins  et al.,  2001).
Depressive  features  are  often  reported  by  people  who
have  MS.  Lifetime  prevalence  of  major depressive  disor-
der  is  approximately  30% (Boeschoten  et  al.,  2017), about
four  times  the rate  reported  in the general  population
(Schürmann  &  Margraf,  2018;  Weinberger  et  al.,  2018)
and  in  line  with  other  neurological  conditions  (e.g.,  Nieto,
Hernández-Torres,  Pérez-Flores,  & Montón,  2018).  The  high
prevalence  may  have  multiple  etiologies,  including  psy-
chosocial  factors  such  as  the difficulty  to  deal  with  one’s
emotions,  and lack  of social  support  (Gay,  Vrignaud,  Garitte,
&  Meunier,  2010). Depression  is  one of  the  main  deter-
minants  of  QOL, and  may  further  compromise  cognitive
function,  increase  risk  for  suicide  ideation,  impair  rela-
tionships  and  reduce  compliance  with  disease-modifying
treatments  (Feinstein,  2011). In addition  to  research
focusing  on  depression,  people  with  MS  have  also  been  found
to  have  high  levels  of  anxiety  (Wood  et  al.,  2012).  Anxiety  is
reported  to  impact  between  23.5%  and  44%  of people  with
MS  (Wood  et al.,  2013).
Physical  symptoms  of  MS vary,  but  fatigue  and  sleep prob-
lems  are among the most  common.  About  80%  of  people
with  MS  report  severe  fatigue  impairments,  and  more  than
half  of them  indicate  these  as  their  most  disabling  symp-
tom  (Rottoli,  La Gioia,  Frigeni,  & Barcella,  2017). Similarly,
sleep  problems,  including  sleep apnea, insomnia,  and rest-
less  legs  syndrome,  are reported  by  about  70%  of  people
with  MS,  although  these  problems  are  often  underdiagnosed
(Brass,  Li, &  Auerbach,  2014).
Despite  the symptoms,  and  having  a major  risk  for  mood
disorders,  several  individuals  with  MS experience  positive
adjustment,  as  reflected  by  a high  level  of  psychoso-
cial  well-being  (Black  & Dorstyn,  2015). Resilience  factors
that  promote  well-being  and quality  of  life  include  social
support,  optimism,  and  spirituality  (Silverman,  Verrall,
Alschuler,  Smith,  & Ehde,  2017). One  of  the psychological
aspects  that  has  received  increasing  attention  in the  gen-
eral area  of  chronic  illness  is  the construct  of mindfulness
(Pagnini  &  Langer,  2015;  Pagnini  &  Phillips,  2015).  Mindful-
ness  is  a multifaceted  and  complex  psychological  concept
that  can be described  from  different  perspectives,  with
two  major frameworks  (Siegel,  2007)  developed  by  Langer
(1989)  and  Kabat-Zinn  (1990),  both  in the 1970s.  Langerian
mindfulness  is  characterized  by  the process  of  active  novel
distinction-making,  as  opposed  to  relying  on  automatic  cat-
egories  created  in  the  past,  enabling  a  person  to  be present
in the  moment  --  that is,  aware  of  the current  context
of  a situation  and  noticing  its  novelties.  Langer’s  primary
components  of mindfulness  are  novelty  seeking,  creativ-
ity,  flexibility,  and  engagement  (Pirson,  Langer,  Bodner,  &
Zilcha-Mano,  2012). In  this  approach  mindfulness  involves
‘‘mind-openness’’,  which  enables  the  potential  for possible
multiple  perspectives.  Therefore,  a  mindful  attitude  rejects
the narrow  view  of  ‘‘good’’  and  ‘‘bad’’,  as  well  as  any
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other  categories  (including  diagnostic  labels).  The  reverse
of  mindfulness,  mindlessness,  consists  of  relying  on  previ-
ously  established  schemas,  which  prevents  the  ability  to  be
in  the  present  (Langer  & Moldoveanu,  2000). Mindlessness  is
being  entangled  in  a  single,  inflexible  perspective,  unaware
of  other  possible  ways  of ‘‘knowing’’  or  understanding  some-
thing.
Kabat-Zinn  (1990)  defines  mindfulness  as  paying  atten-
tion  in  a  purposeful  manner,  in  the  present  moment,  and
non-judgmentally.  This  approach  focuses  on  awareness  and
lack  of  judgment,  and  is  derived  from  the Theravada
Buddhism  tradition.  Most  mindfulness-based  interventions
(MBIs),  including  the mindfulness-based  stress  reduction
(Kabat-Zinn,  1990)  and  the mindfulness-based  cognitive
therapy  (Segal,  Williams,  &  Teasdale,  2002),  refer  to  this
particular  approach  and incorporate  or  are based  on various
forms  of  mindfulness  meditation  (Perestelo-Perez,  Barraca,
Peñate,  Rivero-Santana,  & Alvarez-Perez,  2017).
Despite  sharing  the  same  term  of  ‘‘mindfulness’’,  the two
approaches  refer  to  different  aspects  of the construct.  While
the  contemplative  definition  of  mindfulness  is  often  con-
sidered  an  outcome  (e.g.,  meditation  practice  can  ‘‘lead’’
to  mindfulness),  the  Langerian  model  focuses  on  the pro-
cess,  as  Langerian  mindfulness  is  referred  as  a cognitive
style  (Langer,  1989).  Moreover,  while  Langer’s  perspective
emphasizes  the awareness  of  external  stimuli,  with  no  need
to  attend  to  one’s  own  thought  processes,  the  Kabat-Zinn’s
approach  calls  attention  to both  internal  and external  stim-
uli,  requiring  metacognitive  and  introspective  awareness
(Baer,  2003).  In general,  despite  several  similarities,  the
two  models  refer  to  different  qualities  of  mindfulness,
with  the  Langerian  construct  accentuating  novelty seek-
ing,  flexibility,  curiosity,  and  creativity,  while  Kabat-Zinn’s
approach  stresses  the  moment-to-moment  awareness,  the
acceptance  and  non-judgmental  instance,  and the  involved
meta-cognitive  processes  (Hart,  Ivtzan,  & Hart,  2013).
While  the  Kabat-Zinn  approach  is the most  explored  ver-
sion  of  mindfulness,  there  are increased  concerns  with  a
difficulty  that  reduces  the  impact  of its  primary  therapeutic
process,  i.e.  meditation.  Specifically,  and  despite  common
acceptance  of  the benefits  of this  practice,  the  number
of  people  who  have  tried  meditation  has been  limited  to
as  little  as  8%  (Clarke,  Black,  Stussman,  Barnes,  &  Nahin,
2015), suggesting  restricted  potential  for  the scalability  of
meditation-based  MBIs in  the near  future.  A more  thorough
analysis  of  the meditation  literature  further  suggests  that
some  of  the  positive  clinical  outcomes  reported  may  have
been  overestimated  as  a result  of methodological  flaws  in
studies  included  in meta-analyses  (Goyal  et  al.,  2014).
Both  cross-sectional  investigations  and studies  about MBIs
indicate  that the Kabat-Zinn  approach  to  mindfulness  is  a
potentially  relevant  construct  in the MS experience.  Dispo-
sitional  mindfulness  was  positively  associated  with  QOL  in
individuals  with  MS  (Schirda,  Nicholas,  &  Prakash,  2015).  It
was  also  associated  with  fewer  depressive  symptoms,  as  it
appears  to  be  a mediator  in  the emotional  regulation  process
(Schirda  et  al.,  2015).  Mindfulness  also  appears  to be  related
to  lower  levels  of  pain  (Senders,  Yadav,  & Shinto,  2014), and
to  play  an  important  role  in shaping  dyadic  adjustment  in
couples  coping  with  MS (Pakenham  & Samios,  2013).
The  impact  of  MBIs in  individuals  with  MS has  had  some
promising  results.  In  a  study  by  Grossman  et al. (2010),  150
patients  were  randomly  assigned  to  the intervention  or  to
a  usual  care  group.  The  findings  indicated  an  improvement
of  QOL  and  a  reduction  of  distress.  The  MBI  group  improved
on  non-physical  dimensions  (e.g.,  anxiety  and  depression)
at post  interventions  and  follow  up,  and  baseline  neuropsy-
chological  status  was  not related  to  outcome,  suggesting
that some  form  of MBI  would  be appropriate  for  many
patients  with  MS.  Although  at  the six-month  follow  up  ben-
efits  remained  significant,  there  was  slippage  of effects  for
the  disease-specific  quality  of  life  and  depressive  symptom.
That  raised  the  question  of the duration  of the effects  of
a  mindfulness  intervention;  no  study  has addressed  this  as
of  this publication.  Other  studies  have  investigated  mindful-
ness  and  MS with  limited  samples  with  some methodological
bias,  such  as  the  lack  of an active  control  group.  A system-
atic  review  of  this  topic  (Simpson  et  al.,  2014)  suggested
that  further studies  are  needed  to  clarify  how  such MBIs
might  best serve  the  MS population.  A randomized  con-
trolled  trial  recently  published  by  our  group  indicate  that
online  mindfulness-based  stress  reduction  can  improve  qual-
ity  of  life  and  reduce  anxiety,  depression,  fatigue,  and sleep
problems  (Cavalera  et al.,  2018).  After six months,  how-
ever,  results  were  completely  gone, suggesting  that constant
meditation  practice  may  be required  to  maintain  positive
results.
Studies  on  mindfulness  for  people with  MS  have
either  explored  the correlations  of  this  construct  with
cross-sectional  analyses  or  evaluated  the  effects  of
meditation-based  MBIs.  The  relationship  between  mindful-
ness  as  an  approach  and  well-being  has  not being  explored
in  longitudinal  terms,  except  through  the lens  of  an  MBI.
In  addition,  Langerian  mindfulness  has  not  been explored
in  this  field.  Since  Langer’s  approach  promotes  the  use  of
simple  cognitive  reframing  and  mind-opening  tasks  (Pagnini,
Bercovitz,  & Langer,  2016;  Phillips  & Pagnini,  2014)  and not
meditation,  it has  the  potential  to  overcome  the limits  of
meditation-based  MBIs.  An  exploration  of  how  this  construct
is  associated  with  various  important  psychological  and  phys-
ical  features  of MS could  be highly  relevant.  The  aim  of
the  present  study  is  to  take  a  preliminary  longitudinal  view
of  exploring  the well-being  correlates  to  mindfulness  using
both  approaches  to  mindfulness.
Method
Design
The  study  was  conducted  within  a  larger  study  aimed
to  investigate  the effects  of  an  online  mindfulness-based
stress  reduction  (MBSR)  program  with  an active  control
group  (psycho-education)  on  the  psychological  well-being
of  people  with  MS.  Both interventions  lasted  8 weeks.  The
MBSR  course  followed  the  original  MBSR  structure,  with  few
changes  to fit  the online  context  and  to  adapt  MS clinical
features.  The  psycho-educational  group  included  8-weekly
sessions  with  online  videos  and  home  exercises  that dealt
with  stress  management,  relaxation  training,  sleep hygiene,
fatigue,  and  social  relationships.  The  time  commitment  was
similar  to  the  online  MBSR  course.  Information  about  the
trial  design  is  reported  elsewhere  (Cavalera  et al.,  2016).
The  trial  results  indicate  that  MBSR  promoted  higher  QOL
Please  cite  this article  in press  as:  Pagnini,  F.,  et  al. Longitudinal  associations  between  mindfulness  and




IJCHP-141; No. of Pages 9
4 F. Pagnini  et al.
at  the  post-intervention  assessment,  but  no  differences
between  psycho-education  at a 6-month  follow-up  (Cavalera
et  al.,  2018).
Demographic  data,  together  with  information  about
mindfulness,  quality  of  life, anxiety,  depression,  fatigue,
and  sleep  quality  were collected  from  a  sample  of  people
with  MS.  Participants  were  assessed  at the recruitment  (T1),
after  2  months  (T2),  which  corresponds  to the conclusion  of
the  treatment),  and 6  months  after  the end  of  the treat-
ment  (T3).  Recruitment  and  assessment  procedures  were
conducted  in a  hospital  setting,  at the  Multiple  Sclerosis
Center  of  the don  Gnocchi  Foundation  Hospital.
Participants  signed  an  informed  consent.  Ethical  approval
was  obtained  by  the  Ethics  Committees  of  both Università
Cattolica  del Sacro  Cuore  and the  Don Gnocchi  Foundation.
Participants
The  study  consisted  of  156 persons  with  MS.  Participants
were  considered  eligible  if they  met  the following  crite-
ria:  diagnosis  of  MS  confirmed  by the neurologist;  ability  to
communicate  and understand  tasks;  stable  pharmacological
treatment  for  at least  3 months;  no  clinical  relapses  or  use
of  steroid  treatment  during  the 4  weeks  before  the  enrol-
ment;  and  over  18  years  of age.  Exclusion  criteria  were:
the  presence  of  severe  co-morbidity  that  would reduce  life
expectancy  to  less  than  one  year;  severe  neuropsycholog-
ical  impairment  (e.g.,  dementia),  as  indicated  by  testing
below  the fifth  percentile  in at least  3  of  6 dimensions
of  neuropsychological  functioning  tests  (i.e.,  attention  and
concentration,  processing  speed,  executive  function,  verbal
memory,  and  verbal  processing);  psychosis  or  dissociative
disorders;  and  pregnancy.
Participants  were  inpatients  or  outpatients  at  the Multi-
ple  Sclerosis  Center  of the  don  Gnocchi  Foundation  Hospital
and  were  introduced  to  the  study  by  the neurologists  at
the  center.  They  were  allocated  either  to  the online  MBSR
or  online  psycho-education  programs.  Follow-up  assess-
ments  were  scheduled  with  the participant  and  provided  a
reminder  by  phone  one  week  before.  Dropout  rates were
limited:  156  participants  completed  the first  assessment,
137  completed  the  second  (19  dropouts/12%),  and  115  (22
dropouts/16%)  completed  the entire  study.
Measures
Mindfulness  was  assessed  with  two  questionnaires,  one
developed  for use  in  the Langerian  approach  (the  Langer
Mindfulness  Scale,  or  LMS)  and one  for  the  Kabat-Zinn
approach  (the  Five Facet  Mindfulness  Questionnaire,  or
FFMQ).  The  LMS used  in this study  is  a 14-item  questionnaire
that  assesses  three  domains  describing  mindful  thinking:
novelty  seeking,  engagement,  and novelty  producing  (Pirson
et  al.,  2012).  Items  use  a  7-point  Likert  scale  ranging  from
1  (strongly  disagree)  to  7  (strongly  agree). The  total  score
ranges  from  to  14  to 98,  with  higher  scores  reflecting  higher
mindfulness  (Haigh,  Moore,  Kashdan,  & Fresco,  2011).  The
FFMQ  consists  of  39  items  that  explore  five  aspects  of  mind-
fulness  in  accord  with  the original  definition  of  Kabat-Zinn:
observing,  describing,  acting  with  awareness,  non-judging,
and  non-reactivity  (Baer,  Smith,  Hopkins,  Krietemeyer,  &
Table  1  Demographics  and  characteristics  of  the  study
sample  (N  =  156).
Demographic  Number  (%)  or  mean  (SD), range
Age  (years)  42.76  (9.13),  19--74
Gender
Male 56  (35.9%)
Female  100 (64.1%)
Disease  duration  (years)  13.79  (7.81),  2--39
Education
Middle school  19  (12.2%)
High  school 75  (48%)
College  graduate 56  (35.9%)
Other  6 (3.8%)
Marital  status
Now married  85  (54.5%)
Widowed 1  (6%)
Divorced  10  (6.4%)
Never  married 60  (38.4%)
RCT  group
MBSR  60  (38.4%)
Psycho-education  96  (61.6%)
LMS 72.74  (12.27),  40--97
FFMQ  131.18  (18.42),  68--175
MSQOL 63.18  (18.44),  5--100
HADS-A  7.43  (4.11),  0--20
HADS-D  4.86  (3.73),  0--16
MFIS-5  34.25  (20.31),  0--100
MOS-SM  36.76  (14.29),  0--75.5
Note. LMS, Langer Mindfulness Scale; FFMQ, Five Facet Mind-
fulness Questionnaire; MSQOL, Multiple Sclerosis Quality of
Life-54; HADS-A/D, Hospital Anxiety and Depression Scale; MFIS-
5, Modified Fatigue Impact Scale; MOS-SM, Medical Outcomes
Study-Sleep Measure.
Toney,  2006). Each  item  is  rated  on  a  5-point  Likert  scale
(1  = never true or  very  rarely  true to  5  =  very  often or  always
true).  The  FFMQ  demonstrated  good  internal  consistency
(Baer et al.,  2008).  Four  of  the  mindfulness  facets  (all  but
acting  with  awareness)  have  been  shown  to  be significantly
correlated  with  meditation  experience.
The  Multiple  Sclerosis  Quality  of  Life-54  (MSQOL)  ques-
tionnaire  was  used to  assess  QOL.  It is  a  multidimensional
health-related  QOL  assessment  tool  that  combines  both
generic  and  MS-specific  items  (Vickrey,  Hays,  Harooni,
Myers,  &  Ellison,  1995). For  this study, we considered  the
mental  health  scale  only.
The  Hospital  Anxiety  and  Depression  Scale  was  used to
assess  depression  and  anxiety.  This  comprises  14  items  rated
on  a  four-point  Likert  scale  (Zigmond  & Snaith,  1983).  The
questionnaire  was  designed  to  screen  for  the presence  and
severity  of  depression  (HADS-D)  and  anxiety  (HADS-A)  in peo-
ple  with  a  physical symptomatology.  For  that reason,  the
scale  mainly  includes  items  that  are not  related  to  somatic
symptoms  of  depression.
The  5-item  Modified  Fatigue  Impact  Scale  (MFIS-5;Kos
et  al.,  2005)  was  used  to  measure  fatigue.  Higher  scores
indicate  a  greater  impact  of  fatigue  on  physical,  cognitive
and  psychosocial  functioning.
Sleep  quality  was  assessed  with  the Medical  Outcomes
Study-Sleep  Measure  (MOS-SM;Mendozzi,  Tronci,  Garegnani,
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&  Pugnetti,  2010). This  instrument  is  composed  of  ten items,
using  a  six-point  Likert  scale  to  record  the  frequency  of
occurrence  in the previous  4  weeks  of symptoms  and  dif-
ficulties  typically  affecting  sleep  and daytime  activities  of
people  with  chronic  illnesses.  It  provides  a  synthetic  index,
for  which  higher  scores  indicate  more  sleep  problems.
Data analysis
Statistical  analyses  were  conducted  on  both  cross-sectional
and  longitudinal  data.  A  within-subjects  was  conducted,
with  group  distinctions  (MBSR  vs.  psycho-education)  con-
sidered  only  to  compare  possible  different  trends. Cross-
sectional  associations  between  mindfulness,  expressed  by
both  the  LMS  and  the FFMQ,  and  the other  considered
outcomes  (QOL,  depression,  anxiety,  fatigue,  and  sleep)
were  analyzed  for  each assessment  time.  Correlations
were  assessed  with  two-tailed  Pearson  correlation  coef-
ficient  (r).  The  relationship  between  mindfulness,  with
both  approaches  considered  independently,  and  the target
outcomes  was  explored  with  linear  mixed  models  (Field,
2013). Time  points  were  formatted  as  time-variant  to  con-
sider  changes  over  time,  and random  effect  was  used  to
account  for intra-subject  variability.  The  covariance  matrix
was  considered  as  auto-regressive  (ARI),  with  heterogeneous
variances  at  the three  assessment  times  --  i.e., the matrix
with  the  fewest  parameters  whose  ‘‘deviance’’  was  not
significantly  different  from  the ‘‘unstructured’’  covariance
matrix  (Heck,  Thomas,  &  Tabata,  2013). Models  resulting
from  the  analysis  of  the associations  between  the  two  mind-
fulness  scores  and  the  target  outcomes  were  compared  with
chi-squares  for  each  outcome.  Data  were  analyzed  with  SPSS
and  R  software.
Results
Descriptive  statistics,  including  demographic  information,
means,  standard  deviations,  and  ranges  for  the considered
outcomes  at  T1  are reported  in Table 1.
All  the  investigated  outcomes  resulted  correlations  at
each  assessment  time,  with  both  the  LMS  and  the FFMQ,
with  the exception  of  the  MOS-SM  and  the LMS  at T1  and  T2.
Correlations  are reported  in  Table 2.
When  separately  conducted,  the analyses  on  both  groups
(MBSR  and  psycho-education)  did not  provide  significant  dif-
ferences.  Reported  results  therefore  refer  to  the overall
sample.  Results  from  mixed  models  indicate  that  for  both
constructs  the mindfulness  scores  are associated  with  higher
QOL,  lower  depression,  lower  anxiety,  lower  fatigue,  and
lower  sleep problems  (see  Figure  1).
Specifically,  the LMS predicted  higher  values,  adjusted
for  time,  of  the MSQOL,  F(1,  405.52)  = 21.16,  p < .001.
Conversely,  it predicted  lower  scores  of: HADS-A,  F(1,
319.57)  =  19.10,  p < .001;  HADS-D,  F(1,  398.81)  =  18.78,
p  <  .001;  MFIS-5,  F(1,458.99)  = 15.58,  p  <  .001;  and  MOS-SM,
F(1,  515.07)  = 4.16,  p = .042.
Similarly,  FFMQ  scores  predicted  similar  outcomes:  higher
MSQOL  scores,  F(1, 284.05)  = 12.31,  p  =  .001,  and  lower
scores  with  HADS-A,  F(1,  296.21)  = 30.999,  p < .001;  HADS-D,
F(1,  411.52)  =  39.03,  p <  .001;  MFIS-5,  F(1,  1414.81)  = 17.25,
p  <  .001;  and  MOS-SM,  F(1,  323.71)  =  16.37,  p < .001.  Addi-
tional  parameters  of  the models  are presented  in Table  3.
Table  2  Correlations  between  the  two  mindfulness  scales  (LMS  and  FFMQ)  and  the considered  outcomes,  across  the  different
assessment time  points.
LMS  FFMQ  MSQOL  HADS-A  HADS-D  MFIS-5  MOS-SM
T1 LMS Pearson’s  r 1 .55** .25** −.21** −.36** −.28** .00
Sig. .000  .002  .007  .000  .000  .980
N 152  149  151  152  152 152 151
FFMQ Pearson’s r .55** 1 .33** −.53** −.55** −.45** −.24**
Sig.  .000  .000  .000  .000  .000  .002
N 149  150  149  150  150 150 149
T2 LMS Pearson’s r 1 .44** .33** −.25** −.32** −.40** −.08
Sig. .000  .000  .003  .000  .000  .338
N 136  135  135  135  135 136 136
FFMQ Pearson’s r .44** 1 .169  −.31** −.32** −.38** −.17*
Sig.  .000  .051  .000  .000  .000  .043
N 135  135  134  134  134 135 135
T3 LMS Pearson’s r 1 .59** .34** −.30** −.39** −.38** −.23*
Sig.  .000  .000  .001  .000  .000  .013
N 115  115  115  115  115 115 115
FFMQ Pearson’s r .59** 1 .18* −.41** −.43** −.37** −.26**
Sig.  .000  .049  .000  .000  .000  .005
N 115  115  115  115  115 115 115
Note. LMS, Langer Mindfulness Scale; FFMQ, Five Facet Mindfulness Questionnaire; MSQOL, Multiple Sclerosis Quality of  Life-54; HADS-
A/D, Hospital Anxiety and Depression Scale; MFIS-5, Modified Fatigue Impact Scale; MOS-SM, Medical Outcomes Study-Sleep Measure;
Sig., significant; correlations are 2-tailed.
* p  < .05.
** p  < .01.
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Figure  1 Associations  between  LMS/FFMQ  and  the  considered  outcomes,  divided  by different  assessment  time  points.
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Table  3  Mixed-effects  models.
LMS  FFMQ
Parameter  b  SE  p 95%  CI  Parameter  b  SE p  95%  CI
MSQOL  Intercept  39.51  5.48  <.001  [28.72,  50.30]  Intercept  47.91  4.68  <.001  [38.69,  57.13]
LMS .34  .07  <.001  [.19,  .49]  FFMQ  .12  .03  .001  [.05,  .18]
HADS-A Intercept  12.03  1.20  <.001  [9.67,  14.39]  Intercept  12.52  1.02  <.001  [10.51,  14.53]
LMS −.07  .01  <.001  [−.10,  −.03]  FFMQ  −.04 .00  <.001  [−.05,  −.02]
HADS-D Intercept  9.34  1.07  <.001  [7.23,  11.45]  Intercept  9.93  .86  <.001  [8.23,  11.63]
LMS −.06  .01  <.001  [−.09,  −.03]  FFMQ  −.03 .00  <.001  [−.05,  −.02]
MFIS-5 Intercept  54.98  5.37  <.001  [44.42,  65.54]  Intercept  51.10  4.11  <.001  [43.03,  59.17]
LMS −.29  .07  <.001  [−.44,  −.14]  FFMQ  −.13 .03  <.001  [−.20,  −.07]
MOS-SM Intercept  43.98  4.03  <.001  [36.05,  51.92]  Intercept  51.61  4.02  <.001  [43.69,  59.52]
LMS −.11  .05  .04  [−.22,  −.004  FFMQ  −.12 .02  <.001  [−.17,  −.06]
Note. LMS, Langer Mindfulness Scale; FFMQ, Five Facet Mindfulness Questionnaire; MSQOL, Multiple Sclerosis Quality of  Life-54; HADS-
A/D, Hospital Anxiety and Depression Scale; MFIS-5, Modified Fatigue Impact Scale; MOS-SM, Medical Outcomes Study-Sleep Measure;
SE, standard error; CI, confidence interval.
Comparing  the models  resulting  from  the  two  mindfulness
instruments  (LMS  and  FFMQ)  for each outcome,  no  statistical
differences  were  found.
Discussion
The  present  study  investigated  the relationship  between
the  two  different  mindfulness  approaches  described  above
and  both  psychological  and  physical  well-being  outcomes  in
people  with MS. These  results  indicate  that  mindfulness  as
defined  in  both the Langerian  and  Kabat-Zinn  approaches
are  associated  with  higher  quality  of  life,  lower  depression
and  anxiety,  lower  levels  of  fatigue,  and  better  sleep.  Lon-
gitudinal  analyses  suggest  that  mindfulness  in both  forms
can  predict  these outcomes  over  time.  These  results  are  in
line  with  the  construct  of  mindfulness  as  a  protective  fac-
tor  against  stress,  also  previously  explored  in cross-sectional
studies  (Schirda  et  al.,  2015). The  identification  of  stable
patterns  over  time  suggests  that  mindfulness  can  exert  a
positive  effect  on the improvement  of  psychological  well-
being.  Further,  a mindful  attitude  predicts higher  sleep
quality  and  lower  fatigue.  This  is  in line  with  previous  studies
that  investigated  the  effect  of  an  MBI  on  several  outcomes,
including  sleep  quality  and fatigue  (Pagnini,  Bosma,  Phillips,
&  Langer,  2014).
The  results  confirm  and extend  the  importance  that
mindfulness  can have  on  the general  quality  of  life  of  peo-
ple  with  MS  including  meditation-based  approaches  and,
for  the  first  time,  the  same  results  using  the Langerian
mindfulness  framework.  As  expected,  there  was  a  strong
correlation  between  the  two  forms  of  mindfulness,  with
similar  impacts  on  well-being.  Despite  the  theoretical  dif-
ferences  between  the two  models,  they  both  refer  to one
construct,  approached  from  two  different  perspectives.
There  is  a  clinical  implication,  however,  that  could  be  rel-
evant.  Even  though  the two  approaches  ultimately  refer  to
different  facets  of  mindfulness,  the ways  to  work  on  the  dif-
ferent  facets  are  not similar.  While the  scientific  community
applauds  meditation-based  interventions,  they  may  be hard
to scale  --  particularly  in settings  focused  on  individuals  with
chronic  illnesses  that  are less  susceptible  to  the relatively
highly  focused  concentration  requirements  of  meditation  or
the  logistical  aspects  of  most current  meditation-based  MBIs
(Pagnini  & Phillips,  2015). The  Langerian  approach  does not
involve  meditation  and  is  framed  as  a set  of techniques  or
skills  that  can  be transmitted  through  educational  sessions
that  employ  simple  cognitive  reframing  exercises  (Carson
&  Langer,  2000). Langer  reported  that  improving  on  mind-
fulness  is  very  simple  (Langer,  1989)  and  it does  not require
the  vast amount  of time  of  a structured  meditation  training.
The  further  exploration  of  mindfulness  training  based  on  this
approach  for  these  types  of  patients  is  therefore  warranted.
The  present  study  includes  several  limitations  that  to
varying  degrees  restrict  the  results.  Although  the sample
size  was  higher  than  most,  if not all,  studies  conducted  in the
field  of  MS about  mindfulness,  it was  still  relatively  small.
All  of  the assessed  outcomes  were also  self-reported,  with
the  possibility  that  fatigue  and  sleep  quality  measures  could
be objectively  different  than perceived  by  the  participants.
Future  studies  could  benefit  from  including  instrumental  and
day-to-day  evaluations,  such  as  actigraph  units  and  ecolog-
ically  momentary  assessments.  Finally,  there  is  an intrinsic
issue  with  mindfulness  assessment  as  it  could  be  a  prob-
lematic  concept  for declarative  knowledge,  potentially  a
confounding  effect  of  metacognition  abilities  (Bercovitz,
Pagnini,  Phillips,  &  Langer,  2017; Brown,  Ryan,  &  Creswell,
2007).
Despite  its  limitations,  the  present  study  provides  a
potentially  significant  basis  of  support  for  mindfulness  as
a  relevant  construct  for  people  with  MS.  The  effects  that
a  mindful  outlook  promotes  over  time  include  higher  psy-
chological  well-being  and  QOL,  a reduction  in anxiety,
depression,  perceived  fatigue,  and  sleep  problems.  Mindful-
ness  can  be addressed  from  multiple  perspectives.  The  two
major  ones  that  were  explored  in this study  lead  to  sim-
ilar  outcomes.  This  could  be  particularly  relevant  for  the
exploration  of  alternative  approaches  to  mainstream  non-
meditation-based  MBIs,  matching  or  potentially  outpacing
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the  limits  of  a meditation  approach  for  some  cohorts  and
represents  a  promising  research  area  for  future  clinical  stud-
ies.
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